Citation Impact
Citing Papers
Matrix Protein CCN1 Is Critical for Prostate Carcinoma Cell Proliferation and TRAIL-Induced Apoptosis
2009 Standout
Polyethylene and biodegradable mulches for agricultural applications: a review
2012 Standout
Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature
1992
Gonadotropin-releasing hormone analogs and prostatic cancer
1988
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
Foreign body reaction to biomaterials
2008 Standout
Cancer to bone: a fatal attraction
2011 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
An Overview of Polylactides as Packaging Materials
2004 Standout
Poly‐Lactic Acid: Production, Applications, Nanocomposites, and Release Studies
2010 Standout
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Polycystic Ovary Syndrome
2005 Standout
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Portrait of PTEN: Messages from mutant mice
2008 StandoutNobel
Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment
1999
Synergy and other interactions in phytomedicines
2001 Standout
Inhibition of 5 α-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY102 (Pygeum africanum) and UR102 (Urtica dioica) extracts
1996
Interaction of sex steroids and prolactin on phosphatases, transaminases, and citric acid in the ventral prostate of male albino rats
1987
Biological degradation of plastics: A comprehensive review
2008 Standout
Clusterin inhibits apoptosis by interacting with activated Bax
2005 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Genetic and hormonal control of male sexual differentiation
1975 StandoutNobel
Familial Incomplete Male Pseudohermaphroditism, Type 2
1974 StandoutNobel
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Familial Incomplete Male Pseudohermaphroditism, Type 1
1974 StandoutNobel
Review : Biodegradability of Synthetic Polymers for Medical and Pharmaceutical Applications: Part 2—Backbone Hydrolysis
1987
Synthesis of biodegradable poly(L ‐lactic acid‐co‐D ,L ‐mandelic acid) with relatively low molecular weight
1989
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Mechanistic implications of plastic degradation
2007 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Metabolism of arginine in lactating rat mammary gland
1977
The Interleukin-8 Pathway in Cancer
2008 Standout
Role of PTEN/PI3K pathway in endothelial cells
2007 StandoutNobel
Properties of lactic acid based polymers and their correlation with composition
2002 Standout
In vivo controlled release of a luteinizing hormone-releasing hormone agonist from poly(dl-lactic acid) formulations of varying degradation pattern
1991
Mechanisms Underlying the Development of Androgen-Independent Prostate Cancer
2006
Binding of a 4-Methyl-4-Aza-Steroid to 5α-Reductase of Rat Liver and Prostate Microsomes
1983
Type I Collagen Receptor (α2β1) Signaling Promotes the Growth of Human Prostate Cancer Cells within the Bone
2006
Synthesis of low-molecular-weight copoly(l-lactic acid/ɛ-caprolactone) by direct copolycondensation in the absence of catalysts, and enzymatic degradation of the polymers
1990
Poly(lactic acid) modifications
2009 Standout
Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization
1972 StandoutNobel
Adhesion behavior of rat lymphocytes to poly(ether)–poly(amino acid) block and graft copolymers
1986
Low‐molecular‐weight copolymers composed of L ‐lactic acid and various DL ‐hydroxy acids as biodegradable carriers
1989
The pathogenesis of benign prostatic hyperplasia
1980 Standout
The conversion of testosterone to 5α-Androstan-17β-ol-3-one (dihydrotestosterone) by Skin Slices Of man
1969
The induction of prostatic hypertrophy in the dog with androstanediol.
1976 Standout
Dihydrotestosterone in prostatic hypertrophy
1970
Synthesis of copoly(d,l-lactic acid) with relatively low molecular weight and in vitro degradation
1989
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Arginine metabolism: nitric oxide and beyond
1998 Standout
Recent Studies on the Mechanism of Action of Testosterone
1972
Works of K Shida being referenced
3alpha-Reduction of dihydrotestosterone in human normal and hypertrophic prostatic tissues.
1975
Analysis of Bone Metastasis of Prostatic Adenocarcinoma in 137 Autopsy Cases
1992
Effects of Estrogen Administration on Testosterone-Induced Growth and Increase in Enzyme Activities in the Ventral Prostate of Castrated Rats
1969
1982
Effect of Testosterone Administration on the Free Amino Acids and Conversion of Arginine to Proline and Glutamate in the Rat Ventral Prostate
1973
Further Studies on Testosterone 5α-Reduction in Rat Ventral Prostate
1972
Biodegradable random copolypeptides of β‐benzyl L ‐aspartate and γ‐methyl L ‐glutamate for the controlled release of testosterone
1983
Fusibility of Poly(N-carboxy α-Amino Acid Anhydride) Materials Treated under Pressure-Heat Conditions and in Vitro-in Vivo Degradation of Hot-Pressed Materials
1984
Properties of Testosterone 5α-Reductase of Purified Nuclear Fraction from Ventral Prostate of Rats
1971
Metabolism of testosterone in prostate. 2. Separation of prostatic 17-beta-ol-dehydrogenase and 5-alpha-reductase.
1965
Arginase in human urogenital tumors.
1972
Pharmacological Response in Male Rats with Controlled Release Formulations of Luteinizing Hormone-Releasing Hormone Agonist
1986
Reduction of 5α-Position of Testosterone in the Rat Ventral Prostate
1969
Efficacy of (D‐Leu6)‐Des Gly‐NH210‐LHRH ethylamide against prostatic cancer
1985
Testosterone metabolism in prostate; formation of androstan-17-beta-ol-3-one and androst-4-ene-3, 17-dione, and inhibitory effect of natural and synthetic estrogens.
1965